eBulletin Logo   eBulletin Index

May 2006 

  

ISPOR e-BULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org. Please share these new ISPOR activities with your colleagues.

 

NEW THIS MONTH

 

**NEW** ISPOR 11th Annual European International Meeting-UPDATES

**UPDATE** Evidence-Based Medicine Symposium

**NEW** Student Activities at 11th Annual International Meeting

**NEW** ISPOR 9th Annual European Congress - UPDATES

**NEW** Value in Health Vol. 9 No. 3 (May/June 2006)

**NEW** ISPOR CONNECTIONS Volume 12, Issue 2 (March/April 2006)

**NEW** ISPOR Special Interest Group (SIG) - UPDATES

**NEW** Over 50 New Positions at the ISPOR Website

 

 IMPORTANT DATES TO REMEMBER

 

Ø      20-24 May 2006 - ISPOR 11th Annual International Meeting, Marriott Philadelphia, Philadelphia, PA, USA

Ø      19 June 2006 - Abstract submission deadline ISPOR 9th Annual European Congress, 28-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

Ø      26 September 2006 - Early registration deadline ISPOR 9th Annual European Congress, 28-31, 2006, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark 

Ø      28-31 October 2006 -  ISPOR 9th Annual European Congress, Radisson SAS Falconer Hotel & Conference Center, Copenhagen, Denmark

 

 ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Asia Consortium and Local Chapter News

8.       Employment in Pharmacoeconomics and Outcomes Research

9.       Membership

 


 

1.      PUBLICATIONS

Top

 

VALUE IN HEALTH

 

**NEW**

 

Value in Health Volume 9, Issue 3, May/June 2006 TABLE OF CONTENTS at: http://www.ispor.org/valueinhealth_index.asp

           

            EDITORIALS

            Where's the Value in Health Care?

Joel W. Hay

 

Substantial Returns to Health-Care Spending: But Do We Spend Too Little or Too Much?

Martin J. Buxton

 

            POLICY AND APPLICATION

            The Return on Investment in Health Care: From 1980 to 2000

Bryan R. Luce, Josephine Mauskopf, Frank A. Sloan, Jan Ostermann, L.

Clark Paramore

 

Economic Evaluation in Health Care: The Point of View of Informed Physicians

Giovanni Fattore, Aleksandra Torbica

 

COMMENTARY

Bringing Health Economic Modeling to the 21st Century

David Eddy

 

The Future of Health Economic Modeling: Have We Gone Too Far or Not Far Enough?

A.      Mark Fendrick

 

What Decision-Makers Want and What They Have Been Getting

Maurice McGregor

           

            EMPIRICAL

Health Resource Utilization and Medical Care Cost of Acute Care Elderly Unit Patients

Ravishankar Jayadevappa, Sumedha Chhatre, Mark Weiner, Donna B. Raziano

 

Cost of Hypoglycemia in Patients with Type 2 Diabetes in Sweden

Linus Jonsson, Bjorn Bolinder, Jonas Lundkvist

 

Linguistic Validation of the US Spanish Work Productivity and Activity Impairment Questionnaire, General Health Version

Mary C. Gawlicki, Margaret C. Reilly, Ana Popielnicki, Kate Reilly

 

ISPOR ELEVENTH ANNUAL INTERNATIONAL MEETING CONTRIBUTED PRESENTATION ABSTRACTS

 

VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS

Manuscripts for Volume 9, Issue 4 will be posted in June 2006. To view these "On-Line Early" manuscripts, simply go to http://www.ispor.org/valueinhealth_index.asp, log on using your membership information, and follow the link.

 

**NEW**

ISPOR CONNECTIONS

 

ISPOR CONNECTIONS: Volume 12, Issue 2, March/June 2006 is now available to the public at: http://www.ispor.org/news/index_new.aspIn this issue:

·         ISPOR 2nd Asia-Pacific Conference: Expanding, ISPOR in Asia & Beyond

·         Presidential Fireside Chat: Postcard from Shanghai

·         ISPOR 2nd Asia-Pacific Conference: Significance for China

·         The Value of Society: A Critical Issue All Along the Development and Marketing of Pharmaceuticals

 


2.      ISPOR MEETINGS AND CONGRESSES

Top

 

EVIDENCE- BASED MEDICINE SYMPOSIUM – WHAT DOES IT MEAN? HOW SHOULD REAL WORLD EVIDENCE BE USED FOR RATIONAL DECISION MAKING? WHAT IS THE FUTURE?  FREE TO ALL ATTENDEES

Co-sponsored by PhRMA Health Outcomes Committee and ISPOR

Sunday, May 21, 2006, 5:00PM-7:00PM

Philadelphia Marriott Downtown, Philadelphia, PA, USA (Prior to the ISPOR 11th Annual International Meeting)      

For more information, go to: www.ispor.org/meetings/phila0506/symposium.asp

 

**UPDATES**

ISPOR 11th ANNUAL INTERNATIONAL MEETING - MAY 20-24, 2006

Philadelphia Marriott Downtown, Philadelphia, PA, USA

 

Please use the PERSONAL MEETING SCHEDULER to plan your days at the 11th Annual International Meeting!

See: ispor.confex.com/ispor/intl2006/scheduler/

 

ISPOR FORUMS

Monday, May 22, 2006, 4:30PM-5:30PM

http://www.ispor.org/meetings/phila0506/052206.asp#forums

What Students Should Know About Medicare Part D

Three speakers will discuss Medicare Part D from various perspectives. The effects of the Medicare Prescription Drug Benefit on providers, beneficiaries, and others will be presented.

 

International Perspectives of Pharmaceutical Risk Management (RM)

This forum will compare and contrast RM from an international perspective and provide an open forum for discussion of international issues regarding RM.

 

Economics, Determinants, & Methods of Analysis of Medication Compliance & Persistence

Methods for use of retrospective data to measure compliance, a checklist for the measurement of compliance in prospective studies, and key issues in the statistical distributions of different compliance measures. Approaches to new methods will be described, focusing on concepts that may improve validity and reliability will be discussed in this forum.

           

Real World Data: Importance, Limitations & Need for Good Research Practices

The ISPOR Task Force on Real-World Data has prepared a draft final report and circulated it for review and comment to a large internal ISPOR Review Group. This forum will review key elements of the draft report, the feedback received from the Review Group, and issues that need further discussion.

 

EBM, HTA and Evidence-based Reimbursement

A new definition of evidence-based medicine (EBM), a set of principles and methods intended to ensure that medical decisions, guidelines, and other health care policies are based on and consistent with good evidence of effectiveness and benefit, will be presented. The need to unify the current definition of EBM (which focuses on health care decisions of the individual) and this new definition of EBM (which focuses on population-based health care decisions) are needed to solve both clinical and value issues. During this forum, EBM, health technology assessment (HTA), and health care policy decisions (such as reimbursement decisions) will be discussed.

 

Issues in Assessing Good Practice Guidelines for Budget Impact Analyses

Task force members will present the key recommendations from the draft task force report about the analytic framework, the inputs and data sources, and reporting format for a budget impact analysis in this forum.

 

Vision 2010 Implementation Task Force Report

During this forum, the ISPOR 2010 task force will share a first version of a new plan establishing proposed actions for ISPOR to meet the vision 2010 objectives.

 

Tuesday, May 23, 2006, 4:45PM-5:45PM

http://www.ispor.org/meetings/phila0506/052306.asp#forums


ISPOR Comments on FDA Patient Reported Outcomes Guidance

During this forum, the ISPOR PRO SIG will discuss ISPOR comments to the draft FDA PRO Guidance, submitted April 4, 2006.

 

Patient Registry Global Strategic Applications

The ISPOR Patient Registry SIG is developing a 'white paper' on how to develop and operationalize patient registries. Key issues in developing, operationalizing, and using a patient registry in health outcomes will be presented during this forum.

 

ISPOR Medical Device & Diagnostics Outcomes Research: Issues & Good

Research Practices

ISPOR has launched an initiative to address methodological issues and good research practices when conducting outcomes research for medical devices and diagnostics. The product of this initiative is a book titled: Medical Device & Diagnostics Outcomes Research: Issues & Good Research Practices (THE BOOK). THE BOOK will address issues related to current health technology assessment methodologies and recommend good outcomes research practices that are specifically "tailored" for fast-paced, medical device and diagnostics technology environment. During this forum, THE BOOK outline and key issues will be presented.

 

ISPOR SPECIAL EVENT - REGISTER NOW AND SAVE 20%

ISPOR ROCKS AT THE HARD ROCK CAFÉ featuring the musical talents of ISPOR members. Be a part of this great networking opportunity! Don't miss out on this one of a kind entertainment experience! Enjoy a buffet complete with appetizers, pasta stations, dessert, and drink ticket. Groove to the sounds of the ISPOR Bands!

Monday, May 22, 2006, 8:15-11:30PM

Hard Rock Café, Philadelphia, PA, USA

Buy your tickets early. Go to: http://www.ispor.org/meetings/phila0506/party.asp

      Early registration fee: US$45.00; Registration fee at meeting: US$55.00

 

SYMPOSIA:

HANDLING ISSUES AROUND MISSING DATA IN ECONOMIC ANALYSIS

sponsored by IMS Health

Monday, May 22, 2006, 1:00PM-2:00PM

For program, go to: http://www.ispor.org/meetings/phila0506/052206.asp#IMS_symp

 

POWERFUL DATA, MEANINGFUL ANSWERS: AN INTRODUCTION TO THE HEALTHCARE COST & UTILIZATION PROJECT (HCUP) Sponsored by the Agency for Healthcare Research and Quality, United States Department of Health and Human Services

Tuesday, May 23, 2006, 7:00AM-8:00AM

For program, go to: http://www.ispor.org/meetings/phila0506/052306.asp#POWERFULDATA

 

HEALTH CARE POLICY DEVELOPMENT USING OUTCOMES RESEARCH Sponsored by the Department of Health Policy, Jefferson Medical College

Tuesday, May 23, 2006, 1:00-2:00PM

For program, go to: http://www.ispor.org/meetings/phila0506/052306.asp#POLICYDEVELOPMENT

     

HOTEL RESERVATIONS:

Reservation Cancellation Policy:

A credit card or guaranteed payment for one nights room and tax is required to reserve a room. The revised deadline for hotel reservation cancellation is May 1, 2006, 5:00PM EDST. Cancellations after May 1, 2006 will incur a 1 room-night deposit

 

Online reservations and additional information at:

http://www.ispor.org/meetings/phila0506/hotel_reservation.asp

 

SPONSORSHIP OPPORTUNITIES:

Sponsorship Opportunities are available at:

             

PROFESSIONAL RECRUITMENT CENTER (PRAP)

Advertise employment opportunities:

Careers

 

For more 11th Annual Meeting program info, go to: http://www.ispor.org/meetings/phila0506/index.asp

 

*****************************************************************************************************

ISPOR 9th ANNUAL EUROPEAN CONGRESS

Radisson SAS Falconer Hotel & Conference Center   

Copenhagen, Denmark • 28-31 October 2006

 

CALL FOR ABSTRACTS DEADLINE: 19 JUNE 2006

To submit your abstract now please go to:

http://ispor.confex.com/ispor/euro9/index.html

 

**UPDATES**

 

FIRST PLENARY SESSION-

Sunday, 29 October 2006, 13:30-15:00

HEALTH TECHNOLOGY ASSESSMENT (HTA) AS A BASIS FOR REIMBURSEMENT AND PRIORITIES IN HEALTH CARE

European and Industry Perspective Speaker: Richard Bergström MScPharm, Managing Director, Swedish Association of the Pharmaceutical Industry, Stockholm, Sweden

Government and Nordic Perspective Speaker: Audun Hagaa MSc, Deputy Director General, Ministry of Health, Oslo, Norway

For more information go to: http://www.ispor.org/congresses/denmark1006/102906.asp

 

SECOND PLENARY SESSION

Monday, 30 October 2006, 9:00-10:30

EVIDENCE BASED MEDICINE (EBM): TIME FOR ASKING CRITICAL QUESTIONS

EBM - Time for Asking Critical Questions?

Speaker: Ivar Sonbo Kristiansen MD, PhD, MPH, University of Oslo, Institute of Health Management and Health Economics, Oslo, Norway

EBM - Emerging Reality and Assorted Myths

Speaker: Paul Glasziou MD, Professor, Department of Primary Health Care Old Road Campus, University of Oxford, Oxford, UK

For more information go to: http://www.ispor.org/congresses/denmark1006/103006.asp

 

THIRD PLENARY SESSION

Tuesday, 31 October 2006, 9:00-10:30

SOCIETAL VALUE OF A QALY

Looking for Willingness to Pay (WTP) Threshold for a QALY-- Does it make sense? -- A Critical View

Speaker: Dorte Gyrd-Hansen PhD, Professor, University of Southern Denmark, Institute of Public Health, Odense, Denmark

Looking for Willingness to Pay (WTP) Threshold for a QALY -- Does it make sense? -- A Practical View

Speaker: Martin Buxton BA Soc Sci, Professor, Brunel University Health Economics Research Group, Uxbridge, Middlesex,  UK

For more information go to : http://www.ispor.org/congresses/denmark1006/103106.asp

 

EXHIBIT OPPORTUNITIES

Register now for Exhibit space:

 

SPONSORSHIP OPPORTUNITIES

Register for sponsorship promotional opportunities:

 

For more 9th Annual European Congress program info, go to:

http://www.ispor.org/congresses/denmark1006/index.asp

 


 

3.      EDUCATION ACTIVITIES

Top

           

ISPOR SHORT COURSES–PRIOR TO ISPOR 11TH ANNUAL INTERNATIONAL MEETING - May 2006

 

Twenty-one short courses including 9 NEW courses will be given this year, with 8 courses on Saturday, May 20, 2006, and 13 courses on Sunday, May 21, 2006.

 

SATURDAY, MAY 20, 2006

 

**NEW**

Qualitative Methods for Quality of Life/Patient-Reported Outcomes

Faculty: Carol Tishelman PhD, RN, Professor, Karolinska Institutet and R& D unit Foundation Stockholms Sjukhem, Stockholm Sweden

 

For full descriptions of ALL Saturday short courses, please visit: http://www.ispor.org/meetings/phila0506/sc_sat.asp

  

SUNDAY, MAY 21, 2006

 

**NEW**

Cost-Effectiveness Analysis alongside Clinical Trials

Faculty: Scott Ramsey MD, PhD, Full Member, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Richard Willke PhD, Senior Director, Group Leader, Global Outcome Research, Worldwide Outcomes Research, US Development Sites Pfizer, Inc., Bridgewater, NJ, USA 

 

**NEW**

Use of Real World Data in Outcomes Research

Faculty: Diana Brixner PhD, RPh, Associate Professor and Department Chair, College of Pharmacy, University of Utah, Salt Lake City, UT, USA; Gregory de Lissovoy, PHD, MPH Senior Research Scientist, Health Analytics Group, United BioSource Corp., Bethesda MD; Daniel M. Huse MA, Practice Leader, Information Products, Thomson Medstat Inc., Cambridge, MA, USA

 

**NEW**

Bayesian Analysis: Advanced

Faculty: Bryan Luce MBA, PhD, Senior Vice President, Science Policy, United BioSource Corporation, Bethesda, MD, USA; Christopher S. Hollenbeak PhD, Surgery and Health Evaluation Sciences, Penn State College of Medicine, Hershey, PA, USA; David Vanness PhD, Assistant Professor of Population Health Sciences, University of Wisconsin Medical School, Madison, WI, USA; Keith R Abrams MSc, Professor of Medical Statistics & Course Director, Centre for Biostatistics & Genetic Epidemiology, Department of Health Sciences, University of Leicester, Leicester, UK

 

**NEW**

Propensity Scores and Comorbidity Risk Adjustment

Faculty: Fadia Shaya MPH, PhD, Assistant Professor/Associate Director, University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD, USA

 

**NEW** 

Patient Registries: Overview & Application

Faculty: Jeff Trotter MBA, President, Ovation Research Group, Highland Park, IL, USA

 

**NEW**

Outcomes Research for Medical Devices & Diagnostics

Faculty: Seema Sonnad PhD, Associate Professor, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA; Stacey Ackerman, MSE, PhD,  Vice President,

Covance Market Access Services, San Diego, CA, USA

 

**NEW**

Case Studies in Pharmaceutical/Biotech Pricing II – Advanced

Faculty: Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD, President, ValueVector (Value Added Business Strategies), Milan, Italy

 

**NEW**

Risk Assessment: Analysis and Management

Faculty: Dennis Raisch PhD, Associate Center Director, Scientific Affairs, VA Cooperative Studies Program, Clinical Research Pharmacy, Albuquerque, NM, USA; Anthony Lockett MD, PhD, MBA, Medical Director, ICO, Leeds, UK; Suellen Curkendall PhD, Principal Investigator, Cerner Health Insights, Vienna, VA, USA 

 

**PLEASE NOTE** There has been a change to the short course, Advanced Quantitative Methods for Quality of Life / Patient-Reported Outcomes.  Please contact jharvey@ispor.org if you have any questions related to the following:

 

Course Description: This course will provide an in-depth discussion of operating characteristics, validity testing, analysis and interpretation with examples of each. It will provide a range of methods that may help to solve common problems encountered with quality of life / patient-reported outcomes.  These include an overview of psychometric validation methods including: a brief overview of Rasch analysis, pragmatic issues in validating a PRO from clinical trial data, ePRO validation, methods of estimation of minimally clinically important differences and alternatives to provide information on interpretation  Clinical trial analysis will include missing data analysis techniques and mixed modelling appropriate to PRO data and study design,  There will be a focus on addressing these issues within the framework provided by the PRO guidance recently released by the SEALD group at the FDA.  Specific examples will be used throughout the course and participants will be asked to complete a short exercise. This course is designed for those with intermediate experience in health-related quality-of-life assessment.

 

For full descriptions of ALL Sunday short courses, please visit: http://www.ispor.org/meetings/phila0506/sc_sun.asp


 

4.      STUDENT NEWS

Top

 

**NEW**

Student activities at the ISPOR 11th Annual International Meeting include:

 

ISPOR Student Leadership Retreat (invitation only)

Sunday, May 21, 2006, 10:00AM-4:00PM

 

ISPOR Student Council Dinner (invitation only)

Sunday, May 21, 2006, 5:00PM-6:30PM

 

ISPOR Icebreaker Reception

Sunday, May 21, 2006, 7:30PM-9:00PM

 

ISPOR Mock Interview Session

Monday, May 22, 2006, 2:00PM-4:00PM

 

ISPOR Student Forum

What Students Should Know About Medicare Part D

International Perspectives Regarding Pharmaceutical Risk Management

The Economics, Determinants, & Methods of Analysis of Medication Compliance & Persistence

Monday, May 22, 2006, 4:30-5:30PM

 

Student Roundtable Discussions at the 11th Annual International Meeting

Tuesday, May 23, 2006, 7:00AM-8:00AM

 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp        


  

5.      ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

SPECIAL INTEREST GROUPS are very important to ISPOR to achieve its mission. Their goals are to: develop consensus; stimulate debate; advance knowledge/understanding; publish good research practices; develop indices & tools for researchers and decision-makers; compile health care information for public; respond to health care public policy.

 

RISK MANAGEMENT SIG

**NEW**

The Risk Management Special Interest Group will present a NEW short course at the ISPOR 11th Annual International Meeting, entitled “Risk Assessment: Analysis and Management”. 

 

Additionally, they will present their analysis of the ISPOR Membership Survey on Risk Perception in a forum at the ISPOR 11th Annual International Meeting, entitled, “International Perspectives Regarding Pharmaceutical Risk Management,” Monday, May 22, 2006, 4:30PM.  The discussion will include a lively debate on international regulatory issues surrounding risk management.  

           

**NEW**

HEALTH TECHNOLOGY ASSESSMENT IN EVIDENCE-BASED REIMBURSEMENT SIG

The ISPOR Value-based Reimbursement SIG and Health Technology Assessment SIG have been combined into a new SIG entitled: Health Technology Assessment in Evidence-based Reimbursement. The new combined Working Groups are:

Health Technology Assessment and Good Research Practices for Reimbursement Decisions Working Group

Global Reimbursement Requirements Working Group

Global Health Technology Assessments Used in Health Care Reimbursement Working Group

Health Technology Assessment of Emerging New Technologies Working Group

 

**NEW**

PATIENT REPORTED OUTCOMES SIG

ISPOR Comments on FDA PRO Guidance will be discussed at the ISPOR PRO SIG Forum. Please attend the Forum on TUESDAY, MAY 23, at 4:45PM - 5:45PM SALON A-LEVEL 5

 

**NEW**

MEDICATION COMPLIANCE & PERSISTENCE SIG

11th Annual International Meeting Activities

Members of the Medication Compliance & Persistence SIG will be presenting two workshops:

 

Monday, May 22nd 2:00-3:00PM

METHODS FOR MEDICATION COMPLIANCE STUDIES: PATIENT COMPLIANCE AS A PREDICTOR OF CLINICAL AND ECONOMIC OUTCOMES

 

Discussion Leaders: Joyce Cramer Associate Research Scientist, Yale University School of Medicine, West Haven, CT, USA, Femida Gwadry-Sridhar PhD, Assistant Professor, University of Western Ontario, and London Health Sciences Centre, London, ON, Canada; Joshua S. Benner PharmD, ScD, Principal, ValueMedics Research, LLC, Falls Church, VA, USA

 

Tuesday, May 23rd 2:15-3:15PM

AN ECONOMIC FRAMEWORK TO UNDERSTAND MEDICATION COMPLIANCE AND PERSISTENCE

 

Discussion Leaders: Judith Shinogle PhD, Senior Economist, RTI, International, Washington, DC, USA; Pamela Peele PhD, VP, Health Economics, UPMC Health  Plan, Pittsburgh, PA, USA; Rachel Elliot PhD, Clinical Senior Lecturer, The University of Manchester, Manchester, UK

 

For further information about the work of this group please attend the forum on Monday, May 22nd at 4:30PM – 5:30PM

THE ECONOMICS, DETERMINANTS, & METHODS OF ANALYSIS OF MEDICATION COMPLIANCE & PERSISTENCE: ISPOR Medication Compliance & Persistence SIG Forum

 

Moderator: Joyce Cramer BS, Medication Compliance & Persistence SIG Chair & Associate Research Scientist, Yale University School of Medicine, West Haven, CT, USA

 

Topic: Methods for Analysis of Compliance and Persistence

The status of the recommended approaches for conducting and/or reviewing
both retrospective and prospective compliance and persistence studies
will be discussed. 

 

Speaker: Andrew Peterson, PharmD, Analyses Standards Leadership Group & Assistant Professor, University of the Sciences in Philadelphia, Philadelphia , PA, USA

 

Topic: Determinants Of Medication Compliance And Persistence

The literature on interventions that have been used to improve compliance has been missing a theoretical framework or hypothesis detailing an expected effect of the intervention on compliance. Examples of frameworks include individual level, interpersonal level and community level factors that may have either a direct effect on compliance or act as a mediator. Models can be developed for researchers developing prospective studies to consider relevant constructs in the development and delivery of interventions to improve compliance.

 

Speaker: Femida Gwadry-Sridhar PhD, RPh, MSc, BSc Phm, Determinants of Compliance & Persistence Working Group Chair & Associate Director Critical Care Research Network and Assistant Professor, Department of Medicine, University of Western Ontario, ON, Canada

 

Topic: Economics of Compliance & Persistence

Economic models of behavior can be related to medication-taking behaviors. Models include: a) derivations of Neumann-Morgenstern utility theory to explain decisions under uncertainty about present and future health production and consumption; b) the quantification by patients of those utilities using stated preference methods; c) bilateral bargaining models to explore patient provider interactions; d) prospect theory models to examine how choices vary depending on the reference point (i.e., original health state) when faced with risk or uncertainty; and e) issues related to time preferences and discount rates.

 

Speaker: Judith Shinogle PhD, MSc, Economics of Compliance and Persistence Leadership Group & Senior Economist, RTI International, Washington, DC, USA

 

**NEW**

PATIENT REGISTRY SIG

PATIENT REGISTRY GLOBAL STRATEGIC APPLICATIONS FORUM

Tuesday, May 23, 2006 4:45PN-5:45PM

 

The Strategic Applications for Patient Registries SIG has focused on consolidating our scope of activities by 1) integrating the US and Global SIGS into one group because of similar interests expressed by teams, and 2) preparing a White Paper to inform how best to develop and operationalize the use of patient registries.  The team has successfully integrated the functions and has had several meetings to discuss key issues regarding how registries are utilized in health outcomes and in the Pharmaceutical industry.  We have approved the core outline for a White Paper, which can serve as a policy guidance document for ISPOR.  

For more information and to join an ISPOR SIG, go to http://www.ispor.org/sigs/sigsindex.asp. The ISPOR SIGs are:

 

HEALTH TECHNOLOGY ASSESSMENT IN EVIDENCE-BASED REIMBURSEMENT SIG

TRANSLATING RESEARCH TO PRACTICE SIG

PATIENT REGISTRY SIG

PATIENT REPORTED OUTCOMES SIG

MEDICATION COMPLIANCE & PERSISTENCE SIG

RETROSPECTIVE DATABASE SIG


 

6.      ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

 

TASK FORCE ACTIVITIES

 

BUDGET IMPACT ANALYSIS TASK FORCE

The Task Force held an intensive face-to-face meeting in March where all details in the Task Force Report were finalized.  Pending review, the Task Force will present their Good Practices Report for publication this summer.

 

They will be presenting the report process, themes and projections during a forum at the ISPOR 11th Annual International Meeting, entitled, “Issues in Assessing Good Practice Guidelines for Budget Impact Analyses,” on Monday, May 22, 2006, 4:30PM.

 


 

7.      ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top

 

LOCAL CHAPTER NEWS

 

For more details on ISPOR Local Chapters, go to: Regional Chapters

 

ISPOR ASIA CONSORTIUM

 

For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp

 


8.  EMPLOYMENT

Top

OVER 50 POSITIONS LISTED AT THE ISPOR WEBSITE: Careers

 

Advertise your positions on ISPOR Website (~1 million hits per month)

 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at  STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available.  Nine student resumes posted!  EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students. If you have any questions, please contact: iprap@ispor.org. For more information, visit our website at Careers 


 

9.  ISPOR MEMBERSHIP

Top

 

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website. 

 


eBulletin Index